METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications

Dongdong Jian, Ying Wang, Liguo Jian(Second Affiliated Hospital of Zhengzhou University), Hao Tang(Henan Provincial People's Hospital), Lixin Rao, Ke Chen, Zhen Jia, Wanjun Zhang(Henan Provincial People's Hospital), Yiran Liu(Henan Provincial People's Hospital), Chen Xu, Xiwen Shen, Chuanyu Gao, Shuai Wang(Westlake University), Muwei Li
Theranostics
January 1, 2020
Cited by 283Open Access
Full Text

Abstract

A modification and inducing endothelial cell inflammatory response as well as atherosclerotic plaque formation. Decreased expression of METTL14 can inhibit endothelial inflammation and atherosclerosis development. Therefore, METTL14 may serve as a potential target for the clinical treatment of atherosclerosis.


Related Papers

No related papers found

Powered by citation graph analysis